Skip to content

Study on the relationship between non-high-density lipoprotein cholesterol and hyperlipidemia acute pancreatitis

Study on the relationship between non-high-density lipoprotein cholesterol and hyperlipidemia acute pancreatitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043122
Enrollment
Unknown
Registered
2021-02-05
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatitis

Interventions

Gold Standard:Serum triglyceride level >= 11.3 mmol/L at the time of onset
serum triglyceride level >= 5.65 mmol/L but < 11.3 mmol/L and venous chyloemia.
Index test:non-HDL-C

Sponsors

Ordos Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Meet the diagnosis of AP: Clinically, it can be diagnosed by meeting 2 of the following 3 characteristics: (1) Abdominal pain consistent with AP. (2) Serum amylase and/or lipase concentrations are at least 3 times higher than the upper limit of normal; (3) Abdominal imaging examination conforms to AP imaging changes. In line with the diagnosis of HLAP: serum triglyceride level >= 11.3 mmol/L at the time of onset; serum triglyceride level >= 5.65 mmol/L but < 11.3 mmol/L with venous chyloemia.

Exclusion criteria

Exclusion criteria: (1) Concomitant pancreatic tumor or autoimmune disease; (2) Patients do not accept clinical trials.

Design outcomes

Primary

MeasureTime frame
SEN, SPE, ACC, AUC of ROC, PPV, NPV;

Countries

China

Contacts

Public ContactCao Xi

Ordos Central Hospital

21969644@qq.com+86 15049880146

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026